Home
>
National Drug Code (NDC)
>
Constulose
Constulose - 45963-439-63 - (Lactulose)
Drug Information of Constulose
| Product NDC: | 45963-439 |
| Proprietary Name: | Constulose |
| Non Proprietary Name: | Lactulose |
| Active Ingredient(s): | 10 g/15mL & nbsp; Lactulose |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Constulose
| Product NDC: | 45963-439 |
| Labeler Name: | Actavis Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA090503 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110228 |
Package Information of Constulose
| Package NDC: | 45963-439-63 |
| Package Description: | 237 mL in 1 BOTTLE (45963-439-63) |
NDC Information of Constulose
| NDC Code | 45963-439-63 |
| Proprietary Name | Constulose |
| Package Description | 237 mL in 1 BOTTLE (45963-439-63) |
| Product NDC | 45963-439 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lactulose |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20110228 |
| Marketing Category Name | ANDA |
| Labeler Name | Actavis Inc. |
| Substance Name | LACTULOSE |
| Strength Number | 10 |
| Strength Unit | g/15mL |
| Pharmaceutical Classes | Osmotic Laxative [EPC],Osmotic Activity [MoA],Acidifying Activity [MoA],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE] |
